KK
Therapeutic Areas
Surv Biopharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Surv.m-CRA-1 | Oncology (unspecified solid tumors) | Phase 1 |
| In vivo gene therapy viruses (HGF, etc.) | Hepatic diseases, Diabetes mellitus | Preclinical |
| Drug | Indication | Phase |
|---|---|---|
| Surv.m-CRA-1 | Oncology (unspecified solid tumors) | Phase 1 |
| In vivo gene therapy viruses (HGF, etc.) | Hepatic diseases, Diabetes mellitus | Preclinical |